Welcome to LookChem.com Sign In|Join Free

CAS

  • or

52605-99-9

Post Buying Request

52605-99-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

52605-99-9 Usage

General Description

5,6-Dimethoxynicotinaldehyde is a chemical compound with a molecular formula of C9H11NO3. It is categorized under organic compounds known as pyridinecarboxaldehydes, characterized by a pyridine ring bearing an aldehyde and falls under the nicotinaldehyde group of compounds. Its systematic name in the IUPAC nomenclature is 5,6-dimethoxy pyridine-3-carboxaldehyde. It is soluble in organic solvents but little information is available about its specific usage and properties due to its specialized nature in various chemical research and reactions. Its physical and chemical properties may vary based on its state (solid, liquid, or gas) and temperature.

Check Digit Verification of cas no

The CAS Registry Mumber 52605-99-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,2,6,0 and 5 respectively; the second part has 2 digits, 9 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 52605-99:
(7*5)+(6*2)+(5*6)+(4*0)+(3*5)+(2*9)+(1*9)=119
119 % 10 = 9
So 52605-99-9 is a valid CAS Registry Number.

52605-99-9 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Aldrich

  • (ADE000511)  5,6-Dimethoxynicotinaldehyde  AldrichCPR

  • 52605-99-9

  • ADE000511-1G

  • 7,411.95CNY

  • Detail
  • Aldrich

  • (ADE000511)  5,6-Dimethoxynicotinaldehyde  AldrichCPR

  • 52605-99-9

  • ADE000511-1G

  • 7,411.95CNY

  • Detail
  • Aldrich

  • (ADE000511)  5,6-Dimethoxynicotinaldehyde  AldrichCPR

  • 52605-99-9

  • ADE000511-1G

  • 7,411.95CNY

  • Detail
  • Aldrich

  • (ADE000511)  5,6-Dimethoxynicotinaldehyde  AldrichCPR

  • 52605-99-9

  • ADE000511-1G

  • 7,411.95CNY

  • Detail

52605-99-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 5,6-dimethoxypyridine-3-carbaldehyde

1.2 Other means of identification

Product number -
Other names 2,3 dimethoxypyridyl-5 carboxaldehyde

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:52605-99-9 SDS

52605-99-9Relevant articles and documents

D-AMINO ACID OXIDASE INHIBITORS AND THERAPEUTIC USES THEREOF

-

Paragraph 0185, (2019/04/29)

The present invention relates to compounds of Formula (I): or a pharmaceutically acceptable salt thereof, wherein: each of A, B, C, D, and E, independently, is C, N, N—H, O, S, or absent is a single bond or a double bond; each of X, Y, and Z, independentl

Synthesis and evaluation of analogues of the tuberculosis drug bedaquiline containing heterocyclic B-ring units

Choi, Peter J.,Sutherland, Hamish S.,Tong, Amy S.T.,Blaser, Adrian,Franzblau, Scott G.,Cooper, Christopher B.,Lotlikar, Manisha U.,Upton, Anna M.,Guillemont, Jerome,Motte, Magali,Queguiner, Laurence,Andries, Koen,Van den Broeck, Walter,Denny, William A.,Palmer, Brian D.

supporting information, p. 5190 - 5196 (2017/11/01)

Analogues of bedaquiline where the phenyl B-unit was replaced with monocyclic heterocycles of widely differing lipophilicity (thiophenes, furans, pyridines) were synthesised and evaluated. While there was an expected broad positive correlation between lipophilicity and anti-TB activity, the 4-pyridyl derivatives appeared to have an additional contribution to antibacterial potency. The majority of the compounds were (desirably) more polar and had higher rates of clearance than bedaquiline, and showed acceptable oral bioavailability, but there was only limited (and unpredictable) improvement in their hERG liability.

FSH RECEPTOR ANTAGONISTS

-

Page/Page column 90, (2013/04/10)

The invention relates to FSH receptor antagonist according to general formula (I) or a pharmaceutically acceptable salt thereof and to a pharmaceutical composition containing the same. The compounds can be used for the treatment and prevention of endometriosis, for the treatment and prevention of pre-menopausal and peri-menopausal hormone-dependent breast cancer, for contraception, and for the treatment of uterine fibroids and other menstrual-related disorders

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 52605-99-9